GlassScriptPhysician profile
Shohba Rao
NPI 1861473613
$2,085.90
in general payments reported to CMS, 2019-2025
32 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $158 · 2021: $281 · 2022: $432 · 2023: $492 · 2024: $275 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $299.39 | 2021-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $161.34 | 2021-2025 | |
| Boston Scientific Corporation | $159.36 | 2022-2023 | Solyx Sis System |
| Abbvie INC. | $151.94 | 2019-2022 | |
| Daiichi Sankyo INC. | $117.92 | 2019-2025 | Injectafer |
| Hologic Sales and Service, LLC | $114.71 | 2019-2023 | Aptima |
| Coopersurgical, INC. | $95.70 | 2022 | |
| Intuitive Surgical, INC. | $94.71 | 2023 | Da Vinci Surgical System |
| Shield Therapeutics INC | $91.54 | 2023-2024 | Accrufer |
| Pfizer INC. | $87.15 | 2019-2022 | |
| Ascend Therapeutics US, LLC | $78.82 | 2021-2023 | |
| Caldera Medical, INC | $74.41 | 2023 | Desara |
| Sumitomo Pharma America, INC. | $68.64 | 2024-2025 | Myfembree |
| Biogen, INC. | $57.16 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $53.40 | 2019-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $35.84 | 2023 | Bd Onclarity |
| Therapeuticsmd, INC. | $34.35 | 2020 | |
| Ethicon US, LLC | $32.37 | 2021-2025 | Harmonic |
| Exeltis, USA INC. | $31.60 | 2020-2021 | |
| Monaghan Medical Corporation | $31.39 | 2024 | Aerochamber |
| Myovant Sciences INC. | $30.78 | 2021-2022 | |
| Agile Therapeutics, INC. | $24.68 | 2021 | |
| Northgate Technologies, INC. | $22.66 | 2024 | Stimsite |
| Dexcom, INC. | $22.40 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $19.38 | 2024 | Wegovy |
| Merck Sharp & Dohme LLC | $17.46 | 2019 | |
| Scynexis, INC. | $14.58 | 2022 | |
| Radius Health, INC. | $13.81 | 2020 | |
| Evofem Biosciences, INC. | $13.68 | 2021 | |
| Organon LLC | $12.63 | 2022 | |
| Avanos Medical | $12.58 | 2019 | |
| Channel Medsystems, INC. | $9.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shohba Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.